2024 annual financial data
Arcutis Biotherapeutics 2024 Operating margin
Arcutis Biotherapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -65.33%.
Operating income was -128,397,000 USD and net income was -140,039,000 USD.
Operating cash flow was -112,158,000 USD.
Get free Arcutis Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 196,542,000 USD
- Operating income
- -128,397,000 USD
- Net income
- -140,039,000 USD
- Operating cash flow
- -112,158,000 USD